OR WAIT null SECS
© 2023 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Following positive clinical trial results, Allergan, the makers of bimatoprost, are submitting a new drug application (NDA) to the US Food and Drug Administration (FDA), seeking a new indication for the prostaglandin analogue as an eyelash growth stimulant.